CLINICAL TRIALS PROFILE FOR ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
All Clinical Trials for alogliptin benzoate; metformin hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT03499704 ↗ | A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy | Recruiting | Celltrion Pharm, Inc. | Phase 4 | 2020-02-11 | The purpose of this study is to assess the pioglitazone plus alogliptin plus metformin is non-inferior to dapagliflozin plus alogliptin plus metformin on glycosylated haemoglobin (HbA1c) change from baseline at Week 52. |
| NCT03499704 ↗ | A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy | Recruiting | Takeda | Phase 4 | 2020-02-11 | The purpose of this study is to assess the pioglitazone plus alogliptin plus metformin is non-inferior to dapagliflozin plus alogliptin plus metformin on glycosylated haemoglobin (HbA1c) change from baseline at Week 52. |
| NCT04470310 ↗ | Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination | Active, not recruiting | Seoul National University Hospital | Phase 4 | 2015-12-31 | - This trial is a three-armed, open label, random assignment trial. - The research subjects are patients who are first starting their treatment or patients who have failed with the metformin treatment and are changing their medication. They will be assigned to one of the following treatment groups: the glimepiride monotherapy treatment group, the alogliptin monotherapy treatment group, and the alogliptin - pioglitazone combination therapy treatment group - This trial is a prospective trial which will conduct surveys 6 times over the course of the 6 months in which each treatment group is administered drugs (Week -2, Baseline, Week 4, Week 12, Week 24, follow-up safety survey). - This trial is a multicenter clinical trial which will be conducted at more than 5 general hospital medical institutions in the vicinity of the capital. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for alogliptin benzoate; metformin hydrochloride
Condition Name
Clinical Trial Locations for alogliptin benzoate; metformin hydrochloride
Clinical Trial Progress for alogliptin benzoate; metformin hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for alogliptin benzoate; metformin hydrochloride
Sponsor Name
